Literature DB >> 7981879

Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens.

J Diaz1, D Lévesque, N Griffon, C H Lammers, M P Martres, P Sokoloff, J C Schwartz.   

Abstract

Using in situ hybridization histochemistry in rat nucleus accumbens, we show that the dopamine D3 receptor mRNA is expressed in the ventromedial part of the shell subdivision, where its gross distribution matches that of neurotensin mRNA. In addition, hybridization studies at the cellular level show that a large fraction of the neurotensin neurons co-express the D3 receptor mRNA in this restricted area. In contrast, the dopamine D2 receptor mRNA is expressed mainly in the core and marginally in the shell, at the level of the cone. In rats treated by haloperidol and sulpiride, two D2-like receptor antagonists, but not by SCH 23390, a D1-like receptor antagonist, proneurotensin mRNA was increased in the D2 receptor mRNA-rich areas but decreased in the D3 receptor mRNA-rich areas. This suggests that the D2 and D3 receptors control neurotensin mRNA expression negatively and positively, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981879     DOI: 10.1111/j.1460-9568.1994.tb00329.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

Review 1.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain.

Authors:  J Diaz; S Ridray; V Mignon; N Griffon; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.

Authors:  J Diaz; C Pilon; B Le Foll; C Gros; A Triller; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.

Authors:  P E Holtom; P L Needham; G W Bennett; S Aspley
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 5.  Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.

Authors:  Neil M Richtand
Journal:  Neuropsychopharmacology       Date:  2006-07-19       Impact factor: 7.853

6.  Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.

Authors:  C Betancur; I Lépée-Lorgeoux; M Cazillis; D Accili; S Fuchs; W Rostène
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

7.  A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

Authors:  D Lévesque; M P Martres; J Diaz; N Griffon; C H Lammers; P Sokoloff; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition.

Authors:  Andrés Ciudad-Roberts; Jorge Camarasa; Carlos J Ciudad; David Pubill; Elena Escubedo
Journal:  Br J Pharmacol       Date:  2015-10-09       Impact factor: 8.739

9.  Dosage-dependent effect of dopamine D2 receptor activation on motor cortex plasticity in humans.

Authors:  Shane Fresnoza; Elisabeth Stiksrud; Florian Klinker; David Liebetanz; Walter Paulus; Min-Fang Kuo; Michael A Nitsche
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

Review 10.  Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.

Authors:  L Leriche; J Diaz; P Sokoloff
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.